MX2023005624A - Ligandos peptidicos biciclicos especificos para el receptor de transferrina 1 (tfr1). - Google Patents

Ligandos peptidicos biciclicos especificos para el receptor de transferrina 1 (tfr1).

Info

Publication number
MX2023005624A
MX2023005624A MX2023005624A MX2023005624A MX2023005624A MX 2023005624 A MX2023005624 A MX 2023005624A MX 2023005624 A MX2023005624 A MX 2023005624A MX 2023005624 A MX2023005624 A MX 2023005624A MX 2023005624 A MX2023005624 A MX 2023005624A
Authority
MX
Mexico
Prior art keywords
tfr1
peptide ligands
transferrin receptor
bicyclic peptide
binding complexes
Prior art date
Application number
MX2023005624A
Other languages
English (en)
Spanish (es)
Inventor
Gemma Mudd
Rietschoten Katerine Van
Michael Rigby
Michael Skynner
Ellen Gowans
Punit Seth
Steven STANWAY
Liudvikas Urbonas
Original Assignee
Bicycletx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2017927.1A external-priority patent/GB202017927D0/en
Priority claimed from GBGB2106903.4A external-priority patent/GB202106903D0/en
Application filed by Bicycletx Ltd filed Critical Bicycletx Ltd
Publication of MX2023005624A publication Critical patent/MX2023005624A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
MX2023005624A 2020-11-13 2021-11-12 Ligandos peptidicos biciclicos especificos para el receptor de transferrina 1 (tfr1). MX2023005624A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB2017927.1A GB202017927D0 (en) 2020-11-13 2020-11-13 Bicyclic peptide ligands specific for transferrin
GBGB2106903.4A GB202106903D0 (en) 2021-05-14 2021-05-14 Bicycle peptide ligands specific for transferrin
US202163261820P 2021-09-29 2021-09-29
PCT/GB2021/052927 WO2022101633A1 (en) 2020-11-13 2021-11-12 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)

Publications (1)

Publication Number Publication Date
MX2023005624A true MX2023005624A (es) 2023-05-24

Family

ID=81600834

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023005624A MX2023005624A (es) 2020-11-13 2021-11-12 Ligandos peptidicos biciclicos especificos para el receptor de transferrina 1 (tfr1).

Country Status (13)

Country Link
US (3) US11970555B2 (cg-RX-API-DMAC7.html)
EP (1) EP4244235A1 (cg-RX-API-DMAC7.html)
JP (1) JP7848202B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230107589A (cg-RX-API-DMAC7.html)
CN (1) CN116802190A (cg-RX-API-DMAC7.html)
AR (1) AR126029A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021376917A1 (cg-RX-API-DMAC7.html)
CA (1) CA3201414A1 (cg-RX-API-DMAC7.html)
IL (1) IL302713A (cg-RX-API-DMAC7.html)
MX (1) MX2023005624A (cg-RX-API-DMAC7.html)
SA (1) SA523440745B1 (cg-RX-API-DMAC7.html)
TW (1) TWI921406B (cg-RX-API-DMAC7.html)
WO (1) WO2022101633A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116802190A (zh) 2020-11-13 2023-09-22 拜斯科技术开发有限公司 特异于转铁蛋白受体1(TfR1)的双环肽配体
GB202206431D0 (en) * 2022-05-03 2022-06-15 Bicycletx Ltd Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)
KR20260021596A (ko) * 2023-04-05 2026-02-13 아이오니스 파마수티컬즈, 인코포레이티드 Pln 발현을 감소시키는 화합물 및 방법
EP4788689A1 (en) 2023-10-03 2026-08-12 BicycleTx Limited Bicyclic peptide ligand complexes specific for tfr1
GB202316970D0 (en) * 2023-11-06 2023-12-20 Bicycletx Ltd Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6074574B2 (ja) 2008-02-05 2017-02-08 バイシクル セラピューティクス リミテッド 方法及び組成物
GB0914110D0 (en) 2009-08-12 2009-09-16 Medical Res Council Peptide libraries
CA2967830A1 (en) * 2014-11-14 2016-05-19 Ossianix, Inc. Tfr selective binding compounds and related methods
CN104650186A (zh) 2015-03-09 2015-05-27 中国药科大学 一种能够与TfR1特异性结合的活性肽及其应用
CA2990785C (en) * 2015-06-24 2024-11-12 Jcr Pharmaceuticals Co., Ltd. ANTI-HUMAN TRANSFERRIN RECEPTOR ANTIBODIES CROSSING THE BLOOD-BRAIN BARRIER
GB201706477D0 (en) 2017-04-24 2017-06-07 Bicycle Therapeutics Ltd Modification of polypeptides
EP3615550A1 (en) 2017-04-27 2020-03-04 BicycleTx Limited Bicyclic peptide ligands and uses thereof
JP7670481B2 (ja) 2017-08-04 2025-04-30 バイスクルテクス・リミテッド Cd137に対して特異的な二環式ペプチドリガンド
CA3080351A1 (en) 2017-11-02 2019-05-09 Ossianix, Inc. Improved tfr-selective binding peptides capable of crossing the blood brain barrier
CA3091775A1 (en) * 2018-02-23 2019-08-29 Bicycletx Limited Multimeric bicyclic peptide ligands
WO2020084305A1 (en) 2018-10-23 2020-04-30 Bicycletx Limited Bicyclic peptide ligands and uses thereof
EP3897849A1 (en) * 2018-12-21 2021-10-27 BicycleTx Limited Bicyclic peptide ligands specific for pd-l1
GB201912320D0 (en) * 2019-08-28 2019-10-09 Bicycletx Ltd PBP Binding Bicyclic Peptide Ligands
CN116802190A (zh) 2020-11-13 2023-09-22 拜斯科技术开发有限公司 特异于转铁蛋白受体1(TfR1)的双环肽配体

Also Published As

Publication number Publication date
KR20230107589A (ko) 2023-07-17
JP2023549229A (ja) 2023-11-22
IL302713A (en) 2023-07-01
AU2021376917A1 (en) 2023-06-29
AU2021376917A9 (en) 2024-09-12
CA3201414A1 (en) 2022-05-19
US20240391959A1 (en) 2024-11-28
TWI921406B (zh) 2026-04-11
WO2022101633A1 (en) 2022-05-19
AR126029A1 (es) 2023-09-06
US20220194988A1 (en) 2022-06-23
EP4244235A1 (en) 2023-09-20
SA523440745B1 (ar) 2024-07-24
JP7848202B2 (ja) 2026-04-20
TW202233664A (zh) 2022-09-01
US20250340595A1 (en) 2025-11-06
US11970555B2 (en) 2024-04-30
CN116802190A (zh) 2023-09-22

Similar Documents

Publication Publication Date Title
MX2021013669A (es) Ligandos peptidicos biciclicos especificos para ox40.
PH12020552179A1 (en) Bicyclic peptide ligands specific for nectin-4
SA520420008B1 (ar) جزيئات ترابطية ببتيدية ثنائية الحلقات متعددة الوحدات
WO2022148974A3 (en) Bicyclic peptide ligands specific for nk cells
PH12020550929A1 (en) Bicyclic peptide ligands specific for epha2
SA523440745B1 (ar) (TfR1) ربائط الببتيد ثنائية الحلقة الخاصة بمستقبلات الترانسفيرين 1
JP2022513798A5 (cg-RX-API-DMAC7.html)
SA522431587B1 (ar) مــركب ببتيد ثنائي الحلقة متغاير الترادف
JP2022542286A5 (cg-RX-API-DMAC7.html)
JP2022544058A5 (cg-RX-API-DMAC7.html)
HRP20231570T1 (hr) Peptid za uporabu u imunoterapiji protiv nesitnostaničnog raka pluća i sitnostaničnog raka pluća
PH12014500902A1 (en) Hla-a* 1101-restricted wt1 peptide and pharmaceutical composition comprising the same
WO2005116051A3 (de) An mhc-moleküle bindende tumor-assoziierte peptide
RU2017145014A (ru) Усеченные полипептиды фактора фон виллебранда для лечения гемофилии
Wright et al. The brain hepatocyte growth Factor/c-Met receptor system: A new target for the treatment of Alzheimer's disease
WO2006083961A3 (en) Blys fusion proteins for targeting blys receptor and methods for treatment of b-cell proliferative disorders
JP2023549229A5 (cg-RX-API-DMAC7.html)
CA3228964A1 (en) Inducible cytokine prodrug and pd-1/pd-l1 combination therapy
IL265236B2 (en) Multipurpose medical buildings and their uses
JP2020504081A5 (cg-RX-API-DMAC7.html)
EA202091991A1 (ru) Мультимерные бициклические пептидные лиганды
EA202190105A1 (ru) Бициклические пептидные лиганды, специфичные к нектину-4
DE69926531D1 (de) Gegen gastrointestinale transport rezeptoren gerichtete retro-invertierte peptide und deren verwendung
TH2001007117A (th) ลิแกนด์ เปปไทด์ ไบไซคลิกที่จำเพาะสำหรับเนคทิน-4
EA202191660A1 (ru) Бициклические пептидные лиганды, специфичные к mt1-mmp